It’s not just drugmakers reshaping the pharmaceutical sector; distributors are rapidly transforming, too. While most investors and policymakers focus on rising prescription drug prices or ...

ADCs combine antibodies with drug payloads for targeted therapy, but complex manufacturing requires monitoring CQAs across multiple entities.

Driven by the growing prevalence of chronic diseases, the need for convenient and cost-effective drug delivery solutions, and ...